FDA NDC Directory · JSON-LD · Markdown

Omvoh

NDC 0002-3116 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namemirikizumab-mrkz
Labeler / ManufacturerEli Lilly and Company
Marketing categoryBiologic License Application · App BLA761279
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsMIRIKIZUMAB (100 mg/mL)
Marketing started20251023
Package count2

External sources

Source: openFDA. Public-domain (CC0).